CLL is second indication approved by FDA for ibrutinib; previously approved for mantle cell lymphoma patients
Louis J. DeGennaro, Ph.D., Named Interim President and CEO
The top national LLS partner helping to make Someday, Today, for blood cancer
Darren Campbell of Hayes Bicycle Group Named Corporate Chair for the Leukemia & Lymphoma Society?s Scenic Shore 150 Bike Tour. Click here to read more.
If you're a member of the media, you can direct all inquiries for The Leukemia & Lymphoma Society's (LLS) Wisconsin Chapter by emailing Karen Ropel at email@example.com or calling 262-785-4228.